US Stock MarketDetailed Quotes

ADPT Adaptive Biotechnologies

Watchlist
  • 2.890
  • +0.010+0.35%
Close Mar 27 16:00 ET
419.32MMarket Cap-1852P/E (TTM)

About Adaptive Biotechnologies Company

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

Company Profile

SymbolADPT
Company NameAdaptive Biotechnologies
Listing Date06/27/2019
Issue Price20.00
Founded2009
CEOMr. Chad Robins
MarketNASDAQ
Employees709
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1165 Eastlake Avenue East
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98109
Phone1-206-659-0067

Company Executives

  • Name
  • Position
  • Salary
  • Chad Robins
  • Chairman of the Board and Chief Executive Officer
  • 8.85M
  • Julie Rubinstein
  • President and Chief Operating Officer
  • 6.54M
  • Dr. Harlan Robins, PhD
  • Chief Scientific Officer
  • 8.46M
  • Francis Lo
  • Chief People Officer
  • --
  • Dr. Sharon Benzeno, PhD
  • Chief Commercial Officer, Immune Medicine
  • 3.24M
  • Tycho Peterson
  • Chief Financial Officer
  • 5.94M
  • Kyle Piskel
  • Principal Accounting Officer and Vice President
  • 1.66M
  • Stacy L. Taylor
  • Senior Vice President, General Counsel and Corporate Secretary
  • --
  • Dr. Michael J. Pellini,M.D.
  • Independent Director
  • 296.33K
  • Peter M. Neupert
  • Lead Independent Director
  • 341.33K
  • Dr. Robert M. Hershberg, M.D.,PhD
  • Independent Director
  • 311.33K
  • Michelle Griffin
  • Independent Director
  • 316.33K
  • Katey Einterz Owen
  • Independent Director
  • 296.33K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg